ArticleReproduction (Cambridge, England)2025
Beneficial effects of melatonin on canine oocyte nuclear maturation via reduction of oxidative stress.
Article in Reproduction (Cambridge, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In brief: Oxidative stress due to high-fat content damages canine oocytes during long period of in vitro maturation and compromises their developmental competence. This paper shows how melatonin protects the oocytes and increases development to metaphase II stage. Results from this study would be applicable to conservation of endangered and other animal species. Abstract: Unlike other domesticated animals, in vitro maturation of canine oocytes results in poor nuclear maturation to the metaphase II stage and high oocyte degeneration. The high-fat content of canine oocytes is the likely cause; it predisposes them to oxidative stress and deleterious reactive oxygen species (ROS). Melatonin (MTN) (potentially acting as a powerful antioxidant) was reported to support in vitro cultured oocytes in other species. In this work, canine cumulus oocyte complexes (COCs) were collected after routine ovariohysterectomy. Immunocytochemistry for expression of melatonin receptors (MTNR-1A and 1B) revealed that both receptors were highly expressed in canine oocytes and there was lower expression in the cumulus cells. Canine COCs matured in vitro in melatonin-supplemented culture at 100 nM concentration in low (5%) O2 incubator had a lower percentage at GV stage (6.7% ± 4.2 vs 19.8% ± 3), a higher MII stage (32.3% ± 6.4 vs 15.81% ± 8.1), lower degeneration (20.5% ± 3.2 vs 45.2% ± 5.15) and higher meiotic resumption (GVBD-MII; 56.2% ± 8.6 vs 19% ± 3), and produced lower ROS (determined after DCHFDA staining) (all P < 0.005) than oocytes cultured in high O2 (20%) incubator. The expression of ROS-regulating genes GPX-1 and catalase was significantly reduced in oocytes cultured with melatonin in low O2 compared with high O2 (P < 0.05). Importantly, the oocyte maturation rate increased significantly when G-IVF PLUS, a commercial culture medium used in human oocyte culture, was supplemented with MTN (P < 0.05). These results support the main objective of this study to analyze the beneficial effects of melatonin and low oxygen tension on both health and the developmental competence of in vitro matured canine oocytes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.